GSK plc
F:GS71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GSK plc
F:GS71
|
UK |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
3
|
3M Co
DUS:MMM
|
US |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
Maravai LifeSciences Holdings Inc
F:MAR
|
US |
|
A
|
ArcelorMittal SA
MAD:MTS
|
LU |
|
F
|
Freeport-McMoRan Inc
BMV:FCX
|
US |
|
Roche Holding AG
MIL:1RO
|
CH |
Wall St Price Targets
GS71 Price Targets Summary
GSK plc
According to Wall Street analysts, the average 1-year price target for GS71 is 24.23 EUR with a low forecast of 16.97 EUR and a high forecast of 33.34 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS71's stock price target?
Price Target
24.23
EUR
According to Wall Street analysts, the average 1-year price target for GS71 is 24.23 EUR with a low forecast of 16.97 EUR and a high forecast of 33.34 EUR.
What is the Revenue forecast for GSK plc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for GSK plc?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 1%.
What is the Net Income forecast for GSK plc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 4%.
